
Misonix, Inc. Net Income | MSON
Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.
Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]
It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.
The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.
Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.
It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.
However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.
Annual Net Income Misonix, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -17.4 M | -7.39 M | -7.61 M | -1.68 M | -1.17 M | 5.57 M | 1.39 M | -2.67 M | 366 K | -3.53 M |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.57 M | -17.4 M | -3.41 M |
References
- Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.
Net Income of other stocks in the Medical devices industry
| Issuer | Net Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Avinger
AVGR
|
-18.3 M | - | -20.74 % | $ 369 K | ||
|
EDAP TMS S.A.
EDAP
|
-19 M | - | - | $ 162 M | ||
|
Neovasc
NVCN
|
-24.9 M | - | - | $ 111 M | ||
|
ShockWave Medical
SWAV
|
147 M | - | - | $ 12.3 B | ||
|
Nevro Corp.
NVRO
|
-113 M | - | - | $ 217 M | ||
|
Allied Healthcare Products
AHPI
|
-1.94 M | - | 3.58 % | $ 2.21 M | ||
|
Axonics Modulation Technologies
AXNX
|
-6.09 M | - | - | $ 3.31 B | ||
|
Edwards Lifesciences Corporation
EW
|
1.07 B | $ 105.14 | -0.28 % | $ 61.5 B | ||
|
Cardiovascular Systems
CSII
|
-36.9 M | - | 0.15 % | $ 844 M | ||
|
ThermoGenesis Holdings
THMO
|
-18.9 M | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
-62 M | - | 3.55 % | $ 7.96 M | ||
|
Abiomed
ABMD
|
137 M | - | - | $ 17.2 B | ||
|
Titan Medical
TMDI
|
-14.9 M | - | -26.32 % | $ 19.6 M | ||
|
SmileDirectClub
SDC
|
-86.4 M | - | -53.45 % | $ 9.71 M | ||
|
Cutera
CUTR
|
-57.2 M | - | -10.19 % | $ 1.99 M | ||
|
Sientra
SIEN
|
-22 M | - | -16.59 % | $ 10.3 M | ||
|
Acutus Medical
AFIB
|
-9.55 M | - | -26.83 % | $ 2.62 M | ||
|
Smith & Nephew plc
SNN
|
625 M | $ 30.34 | -0.57 % | $ 26.3 B | ||
|
Viveve Medical
VIVE
|
-22 M | - | -15.35 % | $ 1.71 M | ||
|
Penumbra
PEN
|
178 M | $ 320.36 | 0.39 % | $ 12.5 B | ||
|
Venus Concept
VERO
|
-47 M | - | - | $ 726 K | ||
|
Eargo
EAR
|
-157 M | - | - | $ 10.2 M | ||
|
Surgalign Holdings
SRGA
|
-54.6 M | - | -32.98 % | $ 1.68 M | ||
|
BIOLASE
BIOL
|
-20.6 M | - | -13.19 % | $ 166 K | ||
|
SeaSpine Holdings Corporation
SPNE
|
-54.3 M | - | 0.28 % | $ 270 M | ||
|
Inari Medical
NARI
|
-1.64 M | - | - | $ 4.23 B | ||
|
Viemed Healthcare
VMD
|
15.4 M | $ 8.81 | -2.87 % | $ 343 M | ||
|
Apollo Endosurgery
APEN
|
-39.8 M | - | - | $ 475 M | ||
|
NuVasive
NUVA
|
40.4 M | - | - | $ 2.07 B | ||
|
Conformis
CFMS
|
-50.5 M | - | - | $ 16.4 M | ||
|
Insulet Corporation
PODD
|
247 M | $ 139.95 | -3.71 % | $ 9.85 B | ||
|
ViewRay
VRAY
|
-107 M | - | 1.54 % | $ 468 M | ||
|
Medigus Ltd.
MDGS
|
4.05 M | - | 10.28 % | $ 55.5 M | ||
|
Vapotherm
VAPO
|
-58.2 M | - | 6.72 % | $ 34 M | ||
|
Silk Road Medical, Inc
SILK
|
-55.7 M | - | - | $ 1.07 B | ||
|
TELA Bio
TELA
|
-38.8 M | $ 0.78 | 2.43 % | $ 36.6 M | ||
|
Zynex
ZYXI
|
2.99 M | - | - | $ 21.1 M | ||
|
TransMedics Group
TMDX
|
190 M | $ 96.58 | 2.84 % | $ 3.28 B | ||
|
Natus Medical Incorporated
NTUS
|
13.2 M | - | 1.94 % | $ 1.05 B | ||
|
Nemaura Medical
NMRD
|
-14.1 M | - | -17.8 % | $ 2.74 M | ||
|
Butterfly Network
BFLY
|
-77.1 M | $ 6.11 | 6.0 % | $ 1.51 B | ||
|
Invacare Corporation
IVC
|
-20.6 M | - | - | $ 24.7 M | ||
|
Zimmer Biomet Holdings
ZBH
|
705 M | $ 103.42 | 1.3 % | $ 20.5 B | ||
|
Abbott Laboratories
ABT
|
6.52 B | $ 104.47 | -0.23 % | $ 182 B | ||
|
Align Technology
ALGN
|
410 M | $ 163.89 | 0.26 % | $ 11.9 B | ||
|
Alphatec Holdings
ATEC
|
-143 M | $ 7.08 | 1.95 % | $ 1.06 B | ||
|
Boston Scientific Corporation
BSX
|
2.89 B | $ 43.66 | 1.45 % | $ 64.6 B | ||
|
Cognyte Software Ltd.
CGNT
|
-638 K | $ 7.93 | 1.34 % | $ 578 M | ||
|
Aethlon Medical
AEMD
|
-7.15 M | $ 5.05 | -0.59 % | $ 3.4 M | ||
|
Bio-Rad Laboratories
BIO
|
760 M | $ 369.72 | 3.22 % | $ 10.1 B |